Publication at Faculty of Medicine in Hradec Králové |
2020
Abstract
A case of a patient with a 37-year course of plaque psoriasis successfully responded to risankizumab treatment is described. Due to his profession in medical rescue service, the risks of systemic biological treatment during the COVID-19 pandemic are discussed.